BRTX Valuation

BioRestorative Therapies Inc (BRTX) has a current Price-to-Book (P/B) ratio of 4.11. Compared to its 3-year average P/B ratio of 1.45 , the current P/B ratio is approximately 183.31% higher. Relative to its 5-year average P/B ratio of -1.14, the current P/B ratio is about -462.10% higher. BioRestorative Therapies Inc (BRTX) has a Forward Free Cash Flow (FCF) yield of approximately -109.32%. Compared to its 3-year average FCF yield of -67.04%, the current FCF yield is approximately 63.05% lower. Relative to its 5-year average FCF yield of -58.35% , the current FCF yield is about 87.34% lower.